Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 218,054,544
  • Shares Outstanding, K 1,738,872
  • Annual Sales, $ 41,950 M
  • Annual Income, $ 13,402 M
  • EBIT $ 9,438 M
  • EBITDA $ 12,656 M
  • 60-Month Beta 0.72
  • Price/Sales 5.19
  • Price/Cash Flow 19.19
  • Price/Book 4.28

Options Overview Details

View History
  • Implied Volatility 19.39% (+0.21%)
  • Historical Volatility 18.74%
  • IV Percentile 25%
  • IV Rank 11.61%
  • IV High 42.50% on 04/07/25
  • IV Low 16.36% on 12/10/24
  • Expected Move (DTE 7) 2.49 (1.99%)
  • Put/Call Vol Ratio 0.89
  • Today's Volume 11,207
  • Volume Avg (30-Day) 7,807
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 190,350
  • Open Int (30-Day) 204,814
  • Expected Range 122.91 to 127.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.50
  • Number of Estimates 9
  • High Estimate 1.51
  • Low Estimate 1.49
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +11.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.10 +2.71%
on 11/20/25
132.02 -5.02%
on 11/18/25
-0.40 (-0.32%)
since 11/04/25
3-Month
122.10 +2.71%
on 11/20/25
137.49 -8.79%
on 09/22/25
-7.41 (-5.58%)
since 09/04/25
52-Week
110.86 +13.12%
on 01/15/25
141.23 -11.21%
on 03/04/25
+9.43 (+8.13%)
since 12/04/24

Most Recent Stories

More News
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

ABBOTT PARK, Ill. , Dec. 4, 2025 /PRNewswire/ -- With America's growing focus on wellness and the quality of your years, muscle is emerging as a new metric for aging. That's why Abbott (NYSE: ABT),...

ABT : 125.40 (+0.09%)
How Is Medtronic's Stock Performance Compared to Other Medical Devices Stocks?

Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.

ABT : 125.40 (+0.09%)
IHI : 63.31 (+0.14%)
MDT : 101.99 (+0.02%)
Is Abbott Laboratories Stock Underperforming the S&P 500?

Abbott Laboratories has lagged behind the S&P 500 in recent months as well as over the past year, yet analysts remain strongly bullish on the stock’s prospects.

ABT : 125.40 (+0.09%)
$SPX : 6,857.12 (+0.11%)
BSX : 97.72 (-0.86%)
Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Exact Sciences ...

ABT : 125.40 (+0.09%)
EXAS : 101.13 (-0.12%)
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

ABT : 125.40 (+0.09%)
BMRN : 53.82 (-0.90%)
ABBV : 228.71 (-0.66%)
DXCM : 65.25 (+0.62%)
BIIB : 181.98 (+0.68%)
Exact Sciences Stock Pops on $21 Billion Deal. Is It Too Late to Buy EXAS Here?

Exact Sciences stock rallies as Abbott announces a $21 billion deal to acquire to the molecular diagnostics firm. Here’s why EXAS shares are unlikely to push any higher in 2026.

ABT : 125.40 (+0.09%)
EXAS : 101.13 (-0.12%)
PFE : 25.70 (+0.51%)
Stocks Reverse Course as Nvidia Earnings Rally Fades, VIX Spikes

The S&P 500 Index ($SPX ) (SPY ) today is off by -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is lower by -0.49%. December E-mini...

GOOGL : 317.62 (-0.63%)
AMAT : 269.44 (+0.30%)
AAPL : 280.70 (-1.21%)
NDAQ : 90.29 (+2.23%)
AVGO : 381.03 (+0.11%)
PACS : 31.49 (+0.48%)
DDOG : 153.00 (-1.82%)
J : 140.73 (+1.44%)
$IUXX : 25,581.70 (-0.10%)
BBWI : 19.01 (unch)
ZNH26 : 112-205 (-0.07%)
MSFT : 480.84 (+0.65%)
Stocks Soar on Robust Nvidia Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up by +1.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +1.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +2.09%. December E-mini S&P futures...

GOOGL : 317.62 (-0.63%)
AMAT : 269.44 (+0.30%)
AAPL : 280.70 (-1.21%)
NDAQ : 90.29 (+2.23%)
AVGO : 381.03 (+0.11%)
PACS : 31.49 (+0.48%)
DDOG : 153.00 (-1.82%)
J : 140.73 (+1.44%)
$IUXX : 25,581.70 (-0.10%)
BBWI : 19.01 (unch)
ZNH26 : 112-205 (-0.07%)
MSFT : 480.84 (+0.65%)
Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

ABBOTT PARK, Ill., and MADISON, Wis. , Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement for Abbott to acquire Exact Sciences,...

ABT : 125.40 (+0.09%)
EXAS : 101.13 (-0.12%)
2 Healthcare Stocks Worth Your Attention and 1 We Ignore

2 Healthcare Stocks Worth Your Attention and 1 We Ignore

ABT : 125.40 (+0.09%)
MRK : 100.89 (-1.35%)
BTSG : 35.16 (+0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 127.47
2nd Resistance Point 126.52
1st Resistance Point 125.96
Last Price 125.40
1st Support Level 124.45
2nd Support Level 123.50
3rd Support Level 122.94

See More

52-Week High 141.23
Fibonacci 61.8% 129.63
Fibonacci 50% 126.04
Last Price 125.40
Fibonacci 38.2% 122.46
52-Week Low 110.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar